45 results about "Melatonin secretion" patented technology

A light emitting device to awaken an animal and stimulate the Suprachiasmatic Nucleus in the brain to suppress melatonin secretion. The device can be programmed for an initiation time, color of light, brightness, frequency of pulsating light, and level of gradual intensity. It has the advantage of being silent and does not to disturb other people sleeping in the same room.

Fluorescent lamp 100 has a light color with a correlated color temperature higher than 10000 [K] and lower than 17000 [K] and Duv in a range of −2.5 to 5, comprising arc tube 10 and phosphor layer 20 which includes at least: a red emitting rare-earth phosphor with a main emission peak (11) in 605-625 [nm]; a green emitting rare-earth phosphor with a main emission peak (12) in 540-550 [nm]; and a blue emitting rare-earth phosphor with a main emission peak (13) in 440-460 [nm], an action function efficiency of melatonin suppression for per unit luminous flux is higher than 1.0, and a general color rendering index Ra is 80 or higher. With the stated structure, the fluorescent lamp 100 suppresses melatonin secretion thereby achieving effects of adjusting biological rhythms and promoting wakefulness of living bodies, and also remedies the shortcomings in color rendering characteristics of the light source.

The invention relates to eye-protecting and sleep-facilitating healthy glasses. The glasses are characterized in that according to the light transmittance of lenses, the transmittance of a 400-520 nm spectral interval is 10-35%, the transmittance of a 540-569 nm spectral interval is 35-96%, the transmittance of a 570-600 nm spectral interval is 92-97%, and the transmittance of a 600-700 nm spectral interval is 88-93%. The eye-protecting and sleep-facilitating healthy glasses can stop and optimize a spectrum waveband which is sensed by SCN ganglion cells and can stop melatonin secretion or reduce the secretion amount and will not affect normal work and life of people after being worn, wherein the work and life do not contain work and life needing accurate colors; the glasses serve as a means for improving sleep quality of modern human beings and treating or assisting in treating insomnia of patients with sleep disorder and other symptoms.

Disclosures of the present invention describe a method for inhibiting melatonin secretion. In the present invention, an illumination device is particularly configured for emitting an illumination light with a specific wavelength that is in a range between 581 nm and 590 nm, and a variety of experimental data have proved that the illumination light functions as a melatonin secretion inhibitor. Therefore, the illumination device of the present invention is evidenced to be suitable for use in light therapy, so as to treat seasonal affective disorder (SAD) by way of inhibiting melatonin secretion. Briefly speaking, after a SAD patient receives the irradiation of the illumination light having wavelength ranged in 581-590 nm for a treatment course, the SAD patient is eventually leaded to stay in good spirits and a stable condition of emotion, thereby curing the abnormal symptoms of sleepiness and emotional disorder.

Disclosed in the invention is an intelligent sleeping device. The device is characterized in that more than one light emitting module group is arranged on a main body; and when in use, the light emitting module group faces eyes of the user. According to the invention, the light emitted by the light emitting module group radiates the eyes to simulate the sunlight radiation and thus nnormalization of melatonin secretion of the human body can be promoted, thereby effectively improving sleeping of the user. Therefore, the device can be used for adjusting the normal sleeping of people and improving the sleeping quality of the insomniac; and certain help can be provided for people travelling frequently at long distance to carry out jet lag operation.

The present invention discloses a sleep improving soybean oligopeptide health-care food which is characterized by comprising the following raw materials in mass percentage: 60-70% of soybean oligopeptides, 20-30% of compound sweeteners and 6-12% of honey powder. The provided health-care food has a synergistic use of the advantages of the soybean oligopeptides and honey powder. After the raw materials are blended, the consumption of the health-care food has functions of improving the cerebral blood supply, improving the regulatory function of the cerebral cortex, and thus achieves the roles of calming mind and promoting hypnosis, and calming heart and smoothing nerves, and has a relative good function in improving sleep. Especially the health-care food can enable the nutrients in brain to be balancedly absorbed and promote melatonin secretion, and effectively regulate the human body natural sleep, overcome sleep disorders, improve sleep quality, prevent oxidation, tonify brain cells, and treat intractable insomnia, and is free of reliance with no rebound, and has no side effects on the human body.

The invention discloses a preparation method for an OLED insect-repelling lamp. According to the method, with an OLED, a light-emitting spectrum is controlled based on regulation of a blue-light emitting material, a green-light emitting material, a yellow-light emitting material and a red-light emitting material, so that the light-emitting wavebands are centralized to be at 530nm to 590nm and are at a red-light waveband. And the color rendering index of the OLED is larger than or equal to 65. The preparation method has the following advantages: firstly, the method is simple; with the OLED, the light-emitting spectrum can be controlled based on material regulation and the insect-repelling wavebands from 530nm to 590nm are highlighted in the spectrum, so that the insect-repelling effect is realized; secondly, illumination can be realized well; to be specific, because the light-emitting waveband includes a very few blue-light wavebands of 500nm below and also includes an appropriate number of red-light wavebands, so that the illumination effect is realized; and thirdly, the practicability of the method is high and the color temperature is low; and when the method is applied at night, the injury of the human eyes due to the blue light can be reduced and the suppression on melatonin secretion by the high-color-temperature illumination can be avoided.

The invention discloses an office lighting adjustment method and system. The method comprises the steps of acquiring a preset detection time frame; acquiring whether an office worker is at each office desk or not in real within the detection time frame; turning on an individual light source corresponding to the office desk at which the office worker is when the office worker is at the office desk; adjusting a mode of the individual light source to a highlight state; adjusting a lighting state of the individual light source according to the highlight state; maintaining the lighting state for 30 minutes; and finishing detection and turning off the individual light source. According to the method and the system, disclosed by the invention, the office worker is enabled to receive enough lighting stimulation within an appropriate time frame by adjusting lighting in an office, the influence on melatonin secretion is further generated, so that the working efficiency of the office worker is obviously improved, and the sleep quality of the office worker is adjusted to a certain extent.

The invention provides agents for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm and for improving a circadian rhythm, which may be taken daily and continuously, have excellent safety, and may effectively prevent or ameliorate disorders of an endogenous melatonin secretion rhythm or of a circadian rhythm without administration of exogenous melatonin, as well as functional food containing such an agent, which may prevent or ameliorate various symptoms, such as sleep disorder or prolonged sleep latency. The agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm according to the invention contains whey as the active component. The functional food for improving an endogenous melatonin secretion rhythm according to the invention contains the agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm. The functional food for improving a circadian rhythm contains the agent for improving a circadian rhythm.

The invention provides an application of albiflorin or pharmaceutically acceptable salts of albiflorin to preparation of human melatonin system function improving products. Albiflorin or the pharmaceutically acceptable salts of albiflorin serving as an endogenous melatonin secretion accelerant and a melatonin receptor stimulant can be used for preparing drugs, food, health care products, food additives or nutritional supplements for improving and treating sub-health statuses and/or diseases caused by melatonin system dysfunction, wherein the sub-health statuses are selected from one or more of biological rhythm disorder type sleep disorder, senile sleep disorder, affective disorder, cognitive disorder and immune system dysfunction; the diseases are selected from one or more of depression, anxiety disorder, Alzheimer's disease and Parkinson's disease.

The invention provides a light environment adjusting system and adjusting method suitable for public health safety; the system comprises a lamp with adjustable illumination parameters, a server and asensor; the server is respectively connected with the lamp with adjustable illumination parameters and the sensor, and the system also comprises a terminal device and a physical switch, and the terminal equipment and the physical switch are connected with the server. According to the light environment adjusting system and method suitable for public health safety, the relation between the illumination parameters and melatonin secretion and physiological indexes related to new coronal pneumonia is comprehensively considered, a relation model M1 and a relation model M2 are established, the current scene can be automatically judged, and different illumination environments are provided for different scenes; the lighting requirements in different scenes are met; by providing different illuminations, the patient can maintain biological rhythms and physiological parameters as normal as possible, and recovery of the patient is promoted.

The problem of the present invention is to provide a melatonin secretion regulator capable of regulating melatonin secretion in vivo; this problem is solved by providing a melatonin secretion regulator containing ornithine or a salt thereof as an active ingredient.

The invention provides a blue-light-removing light diffusion material, photocureable coating and LED light source. The blue-light-removing light diffusion material comprises PC, an organosilicon lightdiffusion agent, a nano rare earth oxide and an antioxidant; the blue-light-removing photocureable coating is prepared from UV-cured acrylate, nano rare earth oxide, rare earth naphthenate and elargol; the blue-light-removing LED light source comprises an LED chip, a light-emitting surface of the LED chip is covered with a blue-light-removing fluorescent coating, which comprises fluorescent powder and the blue-light-removing light diffusion material and/or blue-light-removing photocureable coating. By adding rare earth elements in a proper proportion, harmful blue light is reduced, eye pathological harm and human body rhythm harm of myopia, cataract and maculopathy caused by blue light are effectively avoided, harmless blue light is added, melatonin secretion is inhibited, the effect of refreshing people is achieved, meanwhile, spectrum distribution is uniform, uniform and soft light emitting is guaranteed, glare is avoided effectively, and the light source provided by the invention is particularly suitable for replacing a fluorescent lamp in a classroom, so that the eyesight of children is protected.